Find a Doctor
Akshay Muralidhar, MD, is a pulmonologist and the director of the Hereditary Hemorrhagic Telangiectasia (HHT) Program at Barrow Neurological Institute. He is board certified by the American Board of Internal Medicine in the specialties of internal medicine, pulmonary disease, and critical care medicine.
Dr. Muralidhar’s expertise includes the treatment of HHT complications in the lungs, including pulmonary hypertension. He is a member of the American College of Chest Physicians, the American Thoracic Society, and the Pulmonary Hypertension Association.
Dr. Muralidhar earned his medical degree from the University of Arizona, College of Medicine in Tucson. He completed his internal medicine residency at Loyola University Medical Center in Maywood, Illinois, and a pulmonary and critical care medicine fellowship at the University of Colorado Hospital in Aurora.
Dr. Muralidhar’s research interests involve pulmonary vascular disease, specifically pulmonary vascular physiology and right ventricle pulmonary artery coupling. He also has a strong interest in clinical trial research involving both pulmonary hypertension and HHT.
- Fellowship, University of Colorado Hospital, Pulmonary and Critical Care, 2016-2019
- Residency, Loyola University Medical Center, Internal Medicine, 2013-2016
- MD, University of Arizona, College of Medicine, 2013
- BS, University of Arizona, Molecular and Cellular Biology, Computer Science, 2009
- American College of Chest Physicians
- American Thoracic Society
- Pulmonary Hypertension Association
- Pulmonary Vascular Disease Research Career Development Award, University of Colorado, 2018
- Pulmonary Circulation Abstract Scholarship Award, American Thoracic Society, 2018
- Resident Research Scholar, Loyola University Medical Center, 2014-2016
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension
Date: 02/2023
Authors: Hui Zhang, Angelo D'Alessandro, Min Li, Julie A. Reisz, Suzette Riddle, Akshay Muralidhar, Todd Bull, Lan Zhao, Evgenia Gerasimovskaya, Kurt R. Stenmark
Right ventricular function and cardiopulmonary performance among patients with heart failure supported by durable mechanical circulatory support devices
Date: 02/2021
Authors: Tomio Tran, Akshay Muralidhar, Kendall Hunter, Cullen Buchanan, Greg Coe, Michinari Hieda, Christine Tompkins, Matthew Zipse, Melanie J. Spotts, Stephanie G. Laing, Kristina Fosmark, Jordan Hoffman, Amrut V. Ambardekar, Eugene E. Wolfel, Justin Lawley, Benjamin Levine, Wendy M. Kohrt, Jay Pal, William K. Cornwell
New insights into resting and exertional right ventricular performance in the healthy heart through real-time pressure-volume analysis
Date: 07/2020
Authors: William K. Cornwell, Tomio Tran, Lukasz Cerbin, Greg Coe, Akshay Muralidhar, Kendall Hunter, Natasha Altman, Amrut V. Ambardekar, Christine Tompkins, Matthew Zipse, Margaret Schulte, Katie O'Gean, Morgan Ostertag, Jordan Hoffman, Jay D. Pal, Justin S. Lawley, Benjamin D. Levine, Eugene Wolfel, Wendy M. Kohrt, Peter Buttrick
Extensive macrophage accumulation in young and old Niemann-Pick C1 model mice involves the alternative, M2, activation pathway and inhibition of macrophage apoptosis
Date: 03/2016
Authors: Gail Deutsch, Akshay Muralidhar, Ellen Le, Ivan A. Borbon, Robert P. Erickson
Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.
Date: 06/2011
Authors: Akshay Muralidhar, Ivan A Borbon, Dyadin M Esharif, Wangjing Ke, Rinu Manacheril, Michael Daines, Robert P Erickson
- English
Akshay Muralidhar, MD, is a pulmonologist and the director of the Hereditary Hemorrhagic Telangiectasia (HHT) Program at Barrow Neurological Institute. He is board certified by the American Board of Internal Medicine in the specialties of internal medicine, pulmonary disease, and critical care medicine.
Dr. Muralidhar’s expertise includes the treatment of HHT complications in the lungs, including pulmonary hypertension. He is a member of the American College of Chest Physicians, the American Thoracic Society, and the Pulmonary Hypertension Association.
Dr. Muralidhar earned his medical degree from the University of Arizona, College of Medicine in Tucson. He completed his internal medicine residency at Loyola University Medical Center in Maywood, Illinois, and a pulmonary and critical care medicine fellowship at the University of Colorado Hospital in Aurora.
Dr. Muralidhar’s research interests involve pulmonary vascular disease, specifically pulmonary vascular physiology and right ventricle pulmonary artery coupling. He also has a strong interest in clinical trial research involving both pulmonary hypertension and HHT.
- Fellowship, University of Colorado Hospital, Pulmonary and Critical Care, 2016-2019
- Residency, Loyola University Medical Center, Internal Medicine, 2013-2016
- MD, University of Arizona, College of Medicine, 2013
- BS, University of Arizona, Molecular and Cellular Biology, Computer Science, 2009
- American College of Chest Physicians
- American Thoracic Society
- Pulmonary Hypertension Association
- Pulmonary Vascular Disease Research Career Development Award, University of Colorado, 2018
- Pulmonary Circulation Abstract Scholarship Award, American Thoracic Society, 2018
- Resident Research Scholar, Loyola University Medical Center, 2014-2016
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension
Date: 02/2023
Authors: Hui Zhang, Angelo D'Alessandro, Min Li, Julie A. Reisz, Suzette Riddle, Akshay Muralidhar, Todd Bull, Lan Zhao, Evgenia Gerasimovskaya, Kurt R. Stenmark
Right ventricular function and cardiopulmonary performance among patients with heart failure supported by durable mechanical circulatory support devices
Date: 02/2021
Authors: Tomio Tran, Akshay Muralidhar, Kendall Hunter, Cullen Buchanan, Greg Coe, Michinari Hieda, Christine Tompkins, Matthew Zipse, Melanie J. Spotts, Stephanie G. Laing, Kristina Fosmark, Jordan Hoffman, Amrut V. Ambardekar, Eugene E. Wolfel, Justin Lawley, Benjamin Levine, Wendy M. Kohrt, Jay Pal, William K. Cornwell
New insights into resting and exertional right ventricular performance in the healthy heart through real-time pressure-volume analysis
Date: 07/2020
Authors: William K. Cornwell, Tomio Tran, Lukasz Cerbin, Greg Coe, Akshay Muralidhar, Kendall Hunter, Natasha Altman, Amrut V. Ambardekar, Christine Tompkins, Matthew Zipse, Margaret Schulte, Katie O'Gean, Morgan Ostertag, Jordan Hoffman, Jay D. Pal, Justin S. Lawley, Benjamin D. Levine, Eugene Wolfel, Wendy M. Kohrt, Peter Buttrick
Extensive macrophage accumulation in young and old Niemann-Pick C1 model mice involves the alternative, M2, activation pathway and inhibition of macrophage apoptosis
Date: 03/2016
Authors: Gail Deutsch, Akshay Muralidhar, Ellen Le, Ivan A. Borbon, Robert P. Erickson
Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.
Date: 06/2011
Authors: Akshay Muralidhar, Ivan A Borbon, Dyadin M Esharif, Wangjing Ke, Rinu Manacheril, Michael Daines, Robert P Erickson
- English